U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07262671) titled 'Predictive Value of Exosomes in Pleural Effusion for Advanced Lung Cancer' on Nov. 23.
Brief Summary: The goal of this observational study is to investigate the predictive value of exosome characteristics in patients with advanced non-small cell lung cancer (NSCLC) and malignant pleural effusion (MPE). The main question it aims to answer is:
Can the long RNA profile of exosomes derived from plasma and malignant pleural effusion predict treatment response in patients with advanced NSCLC and MPE? Participants who are scheduled to receive standard systemic therapy (including immunotherapy, chemotherapy, or targeted therapy) as part of ...